Dougherty's Pharmacy, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 8/07/2017
Contact Info
  • 5924 ROYAL LANE
  • SUITE 250
  • DALLAS, TX 75230

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Deregistered a/o Feb 15, 2008
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001080029
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5912 - Drugstores and Proprietary Stores
Incorporated In: DE, USA
Year of Inc. 2000
Employees Not Available
Company Officers/Contacts
Mark Heil President, CFO, Secretary
Andrew John Komuves, Jr. COO
Robin Bruce Controller
Geralyn DeBusk IR
Company Directors
James Leslie Chairman
Anthony LeVecchio
Will Cureton
Troy D. Phillips
Company Notes
  • Formerly=Ascendant Solutions, Inc. until 6-2017
  • Note=10-00 State of Incorporation Texas changed to Delaware concurrent with name change
  • Formerly=ASD Systems, Inc. until 10-00
Service Providers
Accounting/Auditing Firm
Whitley Penn
8343 Douglas Avenue
Suite 400
Dallas, TX, 75225
United States

Legal Counsel
Faust Law Group
Investor Relations Firm
Halliburton Investor Relations & Communications
14651 Dallas Parkway
Suite 800
Dallas, TX, 75254
United States

MYDP Security Details
Share Structure
Market Value1 $3,281,616 a/o Oct 19, 2017
Authorized Shares 50,000,000 a/o Aug 04, 2017
Outstanding Shares 22,476,821 a/o Aug 07, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 16,479,813 a/o Aug 04, 2017
Par Value 0.0001
Shareholders of Record 114 a/o Aug 04, 2017
Short Selling Data
Short Interest 2,202 (349.39%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security